Ocular toxicity of fluoroquinolones.
Thompson AM.
Clin Exp Ophthalmol. 2007 Aug;35(6):566-77. doi: 10.1111/j.1442-9071.2007.01552.x.
Brown's syndrome.
Wilson ME, Eustis HS Jr, Parks MM.
Surv Ophthalmol. 1989 Nov-Dec;34(3):153-72. doi: 10.1016/0039-6257(89)90100-8.
T Helper 2 IL-4/IL-13 Dual Blockade with Dupilumab Is Linked to Some Emergent T Helper 17‒Type Diseases, Including Seronegative Arthritis and Enthesitis/Enthesopathy, but Not to Humoral Autoimmune Diseases.
Bridgewood C, Wittmann M, Macleod T, Watad A, Newton D, Bhan K, Amital H, Damiani G, Giryes S, Bragazzi NL, McGonagle D.
J Invest Dermatol. 2022 Oct;142(10):2660-2667. doi: 10.1016/j.jid.2022.03.013. Epub 2022 Apr 6.
Brown Syndrome.
Fu L, Gurnani B, Malik J.
2024 Mar 3. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Advances in clinical examination of lacrimal gland.
Lin Y, Zhang Y, Shi K, Wu H, Ou S.
Front Med (Lausanne). 2023 Aug 31;10:1257209. doi: 10.3389/fmed.2023.1257209. eCollection 2023.
Guillain-Barré syndrome.
Gurwood AS, Drake J.
Optometry. 2006 Nov;77(11):540-6. doi: 10.1016/j.optm.2006.06.014.
Diplopia and fluoroquinolones.
Fraunfelder FW, Fraunfelder FT.
Ophthalmology. 2009 Sep;116(9):1814-7. doi: 10.1016/j.ophtha.2009.06.027. Epub 2009 Jul 30.
Platelet lysate: a promising candidate in regenerative medicine.
Meftahpour V, Malekghasemi S, Baghbanzadeh A, Aghebati-Maleki A, Pourakbari R, Fotouhi A, Aghebati-Maleki L.
Regen Med. 2021 Jan;16(1):71-85. doi: 10.2217/rme-2020-0065. Epub 2021 Feb 5.
Mitochondrial bioenergetics in ocular fibroblasts of two myasthenia gravis cases.
Europa TA, Nel M, Lebeko MR, Heckmann JM.
IBRO Neurosci Rep. 2022 Apr 21;12:297-302. doi: 10.1016/j.ibneur.2022.04.007. eCollection 2022 Jun.
Compartmentalization of extraocular muscle function.
Demer JL.
Eye (Lond). 2015 Feb;29(2):157-62. doi: 10.1038/eye.2014.246. Epub 2014 Oct 24.
